Ciprofloxacin is an antibiotic used for the treatment of urinary tract infections (UTIs). It is estimated that 10% of patients treated with ciprofloxacin will have a recurrent UTI within three weeks of treatment. A new drug has been produced for the treatment of UTIs. In a group of 347 patients who were treated with the new drug, only 29 had a recurrent UTI within three weeks of treatment. Can we conclude that the new drug is effective in reducing the proportion of patients with recurrent UTIs below 10%? Use a hypothesis test with a significance level of a = 0.05.